The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research Group.  [electronic resource] 

 -  JAMA  Nov 1973 
 - 652-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0098-7484 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anticholesteremic Agents--therapeutic use<br/>Clinical Trials as Topic<br/>Clofibrate--therapeutic use<br/>Coronary Disease--drug therapy<br/>Dextrothyroxine--therapeutic use<br/>Drug Evaluation<br/>Drug Therapy, Combination<br/>Estrogens, Conjugated (USP)--administration & dosage<br/>Follow-Up Studies<br/>Humans<br/>Lipoproteins, LDL--blood<br/>Lipoproteins, VLDL--blood<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--diagnosis<br/>Nicotinic Acids--therapeutic use<br/>Placebos<br/>Recurrence<br/>Sodium<br/>Time Factors